Literature DB >> 11304807

Defining a molecularly normal colon.

K J Murphy1, K R Nielson, K H Albertine.   

Abstract

As techniques evolve that allow molecular characterization of disease processes such as cancer, definition of "normal" at a molecular level becomes increasingly important. Increasingly large numbers of mutations are found at the genomic level, but whether all of those mutations contribute to the malignant state of a carcinoma cell is not clear. Without knowledge of what constitutes normality on the proteomic level in an organ or cell, we cannot determine what genomic changes are physiologically important. Traditionally, colon cancer is identified and classified by histological criteria. Margins of the colon are defined as "grossly uninvolved" when the histology is indistinguishable from that of normal (free from disease) colon. By using molecular pathology techniques and working backward from colon adenocarcinoma to hypoplastic polyps to presumably normal mucosa, we defined some of those protein differences. Our results may provide a molecular basis for identifying tumor formation and progression in situ.(J Histochem Cytochem 49:667-668, 2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304807     DOI: 10.1177/002215540104900516

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

1.  Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis.

Authors:  Ashish K Tiwari; Susan E Crawford; Andrew Radosevich; Ramesh K Wali; Yolanda Stypula; Dhananjay P Kunte; Nikhil Mutyal; Sarah Ruderman; Andrew Gomes; Mona L Cornwell; Mart De La Cruz; Jeffrey Brasky; Tina P Gibson; Vadim Backman; Hemant K Roy
Journal:  Cancer Lett       Date:  2011-04-14       Impact factor: 8.679

2.  Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.

Authors:  Yang Wang; Yoshiaki Azuma; David Moore; Neil Osheroff; Kristi L Neufeld
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

3.  Adenomatous polyposis coli in cancer and therapeutic implications.

Authors:  Olivia Noe; Louis Filipiak; Rachel Royfman; Austin Campbell; Leslie Lin; Danae Hamouda; Laura Stanbery; John Nemunaitis
Journal:  Oncol Rev       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.